At the news
? NEUTRALIMPACT 2/10 144 filed Jun 22, 2026 at 16:49 ET
Director Lynn Tetrault filed a Form 144 to sell 37,000 shares via option exercise, valued at approximately $3.58 million, under a 10b5-1 plan adopted on 12/15/2025. The sale is small relative to the company's $6.6B market cap and represents routine insider diversification with no material read-through for the stock.
- Director Lynn Tetrault intends to sell 37,000 shares of common stock.
- Estimated proceeds of $3,581,230 (based on filing price).
- Sale is pursuant to a 10b5-1 plan adopted on 12/15/2025.
- Sale date is 06/22/2026, same day as filing.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access